Inevitable price reduction of simvastatin preparations probable

Influenced by the voluntary reimbursement price cut of MSD Korea's Zocor, which has dominated the domestic anti-hyperlipemic market, the overall price of its generic versions seems likely to be lowered in rows.

MSD Korea said that from this April its insurance price of Zocor 40mg will be reduced to 1,251 won per tablet from 1,877 won, and Cheil Jedang's Simvasta 20mg will also be lowered to ...